Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Value of Dynamic Combination of B-type Natriuretic Peptide and Neutrophil Gelatinase-associated Lipocalin for the Prognosis of Patients With Sepsis

NCT02871544 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.

NCT NCT02871544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02871544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Value of Dynamic Combination of B-type Natriuretic Peptide and Neutrophil Gelatinase-associated Lipocalin for the Prognosis of Patients With Sepsis
Lead sponsor
Southeast University, China
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2015
Completion date
February 29, 2016
Enrollment
124 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

28-day mortality, sepsis